Allogeneic stem cell transplantation for lymphoma: role of conditioning with treosulfan and fludarabine

被引:0
|
作者
Niittyvuopio, R. [1 ]
Heiskanen, J. [1 ]
Lindstrom, V. [1 ]
Juvonen, E. [1 ]
Nihtinen, A. [1 ]
Uotinen, H. [1 ]
Ruutu, T. [1 ]
Volin, L. [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Helsinki, Finland
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S426 / S427
页数:2
相关论文
共 50 条
  • [1] Conditioning with treosulfan and fludarabine for allogeneic blood stem cell transplantation
    Casper, J
    Steiner, B
    Wolff, D
    Kleine, HD
    Wilhelm, S
    Hammer, U
    von Wurmb, N
    Roeber, S
    Wegener, R
    Freund, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S285 - S286
  • [2] Treosulfan in combination with fludarabine as conditioning for allogeneic stem cell transplantation in myelofibrosis
    Kragl, B.
    Heinz, F.
    Grosse-Thie, C.
    Henze, L.
    Lakner, J.
    Freitag, S.
    Wittke, C.
    Brueckner, F.
    Junghanss, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 151 - 152
  • [3] Allogeneic blood stem cell transplantation after treosulfan and fludarabine conditioning
    Casper, J
    Knauf, W
    Schwenke, M
    Steiner, B
    Wolff, D
    Lueck, A
    Leithaeuser, M
    Freund, M
    BONE MARROW TRANSPLANTATION, 2002, 29 : S152 - S152
  • [4] Treosulfan, Fludarabine and Cytarabine As Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation
    Hilgendorf, Inken
    Winkelmann, Nils
    Frietsch, Jochen J.
    Hunstig, Friederike
    Schnetzke, Ulf
    Scholl, Sebastian
    Hochhaus, Andreas
    Casper, Jochen
    BLOOD, 2018, 132
  • [5] Treosulfan/fludarabine as conditioning regimen for allogeneic stem cell transplantation in multiple myeloma.
    Knauf, WU
    Blau, W
    Ruutu, T
    Einsele, H
    Thiel, E
    Freund, M
    Casper, J
    BLOOD, 2003, 102 (11) : 711A - 711A
  • [6] Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
    Remberger, Mats
    Torlen, Johan
    El Serafi, Ibrahim
    Garming-Legert, Karin
    Bjorklund, Andreas
    Ljungman, Per
    Sundin, Mikael
    Hassan, Moustapha
    Mattsson, Jonas
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 106 (04) : 471 - 475
  • [7] Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation
    Mats Remberger
    Johan Törlen
    Ibrahim El Serafi
    Karin Garming-Legert
    Andreas Björklund
    Per Ljungman
    Mikael Sundin
    Moustapha Hassan
    Jonas Mattsson
    International Journal of Hematology, 2017, 106 : 471 - 475
  • [8] Treosulfan/fludarabine - a low toxicity but myeloablative conditioning for allogeneic hematopoietic stem cell transplantation
    Holowiecki, J
    Giebel, S
    Wojnar, J
    Krawczyk-Kulis, M
    Wylezol, I
    Kruzel, T
    Markiewicz, M
    BLOOD, 2004, 104 (11) : 292A - 292A
  • [9] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
  • [10] Fludarabine and treosulfan conditioning for allogeneic stem cell transplantation (SCT) in patients with AML and MDS not eligible for standard myeloablative conditioning: the role of treosulfan dose
    Shimoni, A.
    Peccatori, J.
    Shem-Tov, N.
    Lo Russo, A.
    Yerushalmi, R.
    Bernardi, M.
    Nagler, A.
    Ciceri, F.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S220 - S220